- Scrip Originals
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Pharmazz, Inc.
Korea's GNT Pharma is set to take its first-in-class, multi-targeted stroke therapy Nelonemdaz into Phase III, raising hopes for a new treatment that could sharply reduce disabilities and death in stroke patients.
- Contract Research, Toxicology Testing-CRO